- Home
- SVM vs COLL Comparison
SVM vs COLL Comparison
Compare SVM & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- COLL
- Stock Information
- Founded
- SVM N/A
- COLL 2002
- Country
- SVM Canada
- COLL United States
- Employees
- SVM N/A
- COLL N/A
- Industry
- SVM Precious Metals
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- COLL Health Care
- Exchange
- SVM Nasdaq
- COLL Nasdaq
- Market Cap
- SVM 1.1B
- COLL 958.8M
- IPO Year
- SVM N/A
- COLL 2015
- Fundamental
- Price
- SVM $4.92
- COLL $38.32
- Analyst Decision
- SVM Strong Buy
- COLL Strong Buy
- Analyst Count
- SVM 1
- COLL 4
- Target Price
- SVM $6.75
- COLL $44.25
- AVG Volume (30 Days)
- SVM 4.9M
- COLL 427.8K
- Earning Date
- SVM 08-07-2025
- COLL 08-07-2025
- Dividend Yield
- SVM 0.51%
- COLL N/A
- EPS Growth
- SVM N/A
- COLL N/A
- EPS
- SVM 0.25
- COLL 1.06
- Revenue
- SVM $308,064,000.00
- COLL $707,007,000.00
- Revenue This Year
- SVM $3.27
- COLL $22.23
- Revenue Next Year
- SVM $33.68
- COLL $2.78
- P/E Ratio
- SVM $19.61
- COLL $36.58
- Revenue Growth
- SVM 35.50
- COLL 22.61
- 52 Week Low
- SVM $2.87
- COLL $23.23
- 52 Week High
- SVM $5.32
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- SVM 58.66
- COLL 59.51
- Support Level
- SVM $4.58
- COLL $38.00
- Resistance Level
- SVM $5.18
- COLL $39.78
- Average True Range (ATR)
- SVM 0.20
- COLL 0.97
- MACD
- SVM 0.05
- COLL -0.18
- Stochastic Oscillator
- SVM 70.22
- COLL 38.72
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.